The challenge for our clients is to manage the transition to a sustainable energy mix, achieve carbon neutrality and face price volatility. Our understanding of the regulatory environment has provided clients with the tools to structure funding for new projects or to formulate appropriate power procurement strategies. We have also advised clients on carbon neutrality through the production and/or purchase of carbon offsets through innovative property management arrangements.

The electrification of the grid, as well as the introduction of new form factors in urban mobility have created both opportunities and regulatory challenges. We help navigate complex regulatory environments and put our clients in a position to acquire regulatory assets, break down barriers to entry or to design newly created markets. We have worked on the introduction of ride sharing in Portugal and other related markets, the introduction of micromobility solutions for urban mobility and on the establishment of the electric charging network.

We work with financial institutions on embracing technology or regulatory driven change. We see firms facing increasingly diverse demands on the integration of technology and its regulatory implications. We enable the adoption of new products, tech enabled distribution channels or new methodologies for risk management by giving comprehensive regulatory and commercially sensible advice.
‍
We advise financial sponsors on fund formation and distribution, as well as on investments and divestments. We provide perspective both in terms of risks and opportunities in due diligence, deal structuring and negotiation. Our approach is to create value through negotiation by understanding deal drivers and economics.

In a highly regulated and scrutinized sector, where innovation, research and disruption face a complex set of legislation and constraints, we work with leading companies and public entities on developing their strategic and transformational projects on healthcare, life sciences and pharmaceutical areas. We provide advice to global pharma companies operating at a global level, as well as private healthcare groups in the areas of procurement, contract management, marketing authorizations, taxation, pricing, advertising and wholesale distribution.

We provide advice to public entities and regulators setting up and monetizing procurement policies and strategies as well. We also advise tech infrastructure companies in the healthcare sector, notably on the establishment and operation of the national and European medicines authenticity verification system.

We work with investors and entrepreneurs in fast growing industries, primarily software and deep tech companies on funding, commercial transactions and managing and incentivizing talent. We advise investors and founders on their funding deals, from seed to series A and beyond. We look for flexible and efficient outcomes in negotiations and have a well established track record for VC/PE deals.

We help founders develop their legal strategies across the growth cycle and prioritize work to match the maturity of the business. We have assisted both domestic and international companies on IP protection and copyright, on product design and compliance and on tax and legal structuring for cross border expansion.